CYDAN II, INC.

ANDASI

pharmaceutical products for treating respiratory diseases, sold by prescription only, excluding herbal products;

CALANCE

Pharmaceutical preparations for the treatment of cardiovascular disorders;

CYDAN

The mark consists of the word CYDAN and the design of eight overlapping square shapes which form a roughly circular shape.;The drawing is amended to appear as follows: PUBLISH NEW CUT;Development, incubation and investment services, namely, asset acquisition, asset license acquisition, asset option acquisition, business and financial asset risk management relating to intellectual property, and financial and investment asset management services; Investment and financial consultation; financial services, namely, investment of funds for others in intellectual property and knowledge relating to the treatment of orphan diseases, for the purpose of subsequently forming new biotechnology and pharmaceutical companies which hold rights in such intellectual property and knowledge;Color is not claimed as a feature of the mark.;The color gray represents shading and is not a feature of the mark.;